Literature DB >> 1735595

Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors.

N Jaiswal1, D I Diz, M C Chappell, M C Khosla, C M Ferrario.   

Abstract

Angiotensin II stimulates prostaglandin release in blood vessels via activation of angiotensin receptors present in endothelium, vascular smooth muscle cells, or both. We evaluated the response of angiotensin II, angiotensin I, and [des-Phe8] angiotensin II [angiotensin-(1-7)] on prostaglandin release in porcine aortic endothelial cells. Incubation of cell monolayers with angiotensin I and angiotensin-(1-7), but not angiotensin II, stimulated the release of prostaglandin E2 and prostaglandin I2 in a dose-dependent manner (10(-10) to 10(-6) M) with an EC50 of approximately 1 nM. In addition, we characterized the angiotensin receptor subtypes mediating prostaglandin synthesis by using subtype-selective antagonists. Angiotensin I-stimulated prostaglandin synthesis was not altered by either of the nonselective classical angiotensin receptor antagonists [Sar1,Thr8]angiotensin II or [Sar1,Ile8]angiotensin II. In contrast, either the angiotensin subtype 1 (AT1) antagonist DuP 753 or the subtype 2 (AT2) antagonist CGP42112A significantly attenuated the prostaglandin release in response to angiotensin I. However, PD123177, another AT2 antagonist, did not inhibit angiotensin I-stimulated prostaglandin release. Angiotensin-(1-7)-induced prostaglandin release was significantly attenuated by [Sar1,Thr8]angiotensin II (10(-6) M) and PD123177 (10(-6) M) but not by [Sar1,Ile8]angiotensin II, DuP 753, or CGP42112A. Higher doses (10(-5) M) of DuP 753 and CGP42112A attenuated the angiotensin-(1-7) response. These data suggest that in porcine aortic endothelial cells, angiotensin I and angiotensin-(1-7) but not angiotensin II are potent stimuli for prostaglandin synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735595     DOI: 10.1161/01.hyp.19.2_suppl.ii49

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 2.  Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

Authors:  Douglas M Bennion; Emily Haltigan; Robert W Regenhardt; U Muscha Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

3.  Socially cued seminal fluid gene expression mediates responses in ejaculate quality to sperm competition risk.

Authors:  Leigh W Simmons; Maxine Lovegrove
Journal:  Proc Biol Sci       Date:  2017-08-30       Impact factor: 5.349

Review 4.  Ontogeny of renin and AT1 receptor in the rat.

Authors:  R A Gomez; A Tufro-McReddie; A D Everett; E S Pentz
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 5.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

6.  Increased aortic intimal proliferation due to MasR deletion in vitro.

Authors:  Hiba Alsaadon; Peter Kruzliak; Arthur Smardencas; Alan Hayes; Michael Bader; Peter Angus; Chandana Herath; Anthony Zulli
Journal:  Int J Exp Pathol       Date:  2015-02-10       Impact factor: 1.925

Review 7.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

Review 8.  Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity.

Authors:  Christoph Konradt; Christopher A Hunter
Journal:  Eur J Immunol       Date:  2018-09-21       Impact factor: 5.532

Review 9.  Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Leanne Groban
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

Review 10.  Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.

Authors:  Christoph Schindler; Peter Bramlage; Wilhelm Kirch; Carlos M Ferrario
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.